- Home
- CRVS vs CRMT Comparison
CRVS vs CRMT Comparison
Compare CRVS & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- CRMT
- Stock Information
- Founded
- CRVS 2014
- CRMT 1981
- Country
- CRVS United States
- CRMT United States
- Employees
- CRVS N/A
- CRMT N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- CRMT Other Specialty Stores
- Sector
- CRVS Health Care
- CRMT Consumer Discretionary
- Exchange
- CRVS Nasdaq
- CRMT Nasdaq
- Market Cap
- CRVS 335.1M
- CRMT 303.2M
- IPO Year
- CRVS 2016
- CRMT N/A
- Fundamental
- Price
- CRVS $4.19
- CRMT $44.27
- Analyst Decision
- CRVS Strong Buy
- CRMT Hold
- Analyst Count
- CRVS 5
- CRMT 3
- Target Price
- CRVS $12.38
- CRMT $50.00
- AVG Volume (30 Days)
- CRVS 419.4K
- CRMT 65.3K
- Earning Date
- CRVS 03-18-2025
- CRMT 03-06-2025
- Dividend Yield
- CRVS N/A
- CRMT N/A
- EPS Growth
- CRVS N/A
- CRMT N/A
- EPS
- CRVS N/A
- CRMT N/A
- Revenue
- CRVS N/A
- CRMT $1,357,351,000.00
- Revenue This Year
- CRVS N/A
- CRMT N/A
- Revenue Next Year
- CRVS N/A
- CRMT $4.33
- P/E Ratio
- CRVS N/A
- CRMT N/A
- Revenue Growth
- CRVS N/A
- CRMT N/A
- 52 Week Low
- CRVS $1.30
- CRMT $37.98
- 52 Week High
- CRVS $10.00
- CRMT $74.10
- Technical
- Relative Strength Index (RSI)
- CRVS 28.71
- CRMT 33.02
- Support Level
- CRVS $4.60
- CRMT $47.47
- Resistance Level
- CRVS $5.19
- CRMT $52.40
- Average True Range (ATR)
- CRVS 0.30
- CRMT 2.03
- MACD
- CRVS -0.06
- CRMT -0.42
- Stochastic Oscillator
- CRVS 2.01
- CRMT 3.73
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in us focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The Company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It primarily sells older model used vehicles and provides financing for substantially all of its customers. The Company earns revenue from the sale of used vehicles and in most cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.